Páll Thor Ingvarsson

Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach

Fabrice Rose, Jeanette Erbo Wern, Páll Thor Ingvarsson et al. · Journal of Controlled Release · 2015 · 94 citations

Nanoparticles, Lipid Preparation, Engineering +5

Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process

Páll Thor Ingvarsson, Mingshi Yang, Helle Mulvad et al. · Pharmaceutical Research · 2013 · 49 citations

Lipid Preparation, Biomanufacturing, Engineering +5

Designing CAF-adjuvanted dry powder vaccines: Spray drying preserves the adjuvant activity of CAF01

Páll Thor Ingvarsson, S. Schmidt, Dennis Valbjørn Christensen et al. · Journal of Controlled Release · 2013 · 43 citations

Vaccination, Cross-protection, Vaccine Development +10

Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder

Aneesh Thakur, Páll Thor Ingvarsson, S. Schmidt et al. · Vaccine · 2018 · 34 citations

Vaccination, Vaccine Development, Tuberculosis Prevention +8

The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models

Páll Thor Ingvarsson, Ida Svahn Rasmussen, Michelle Viaene et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2014 · 21 citations

Proteinlipid Interaction, Biochemistry, Cellular Biology +11